Blood lactate in mild and moderate ARDS secondary to SARS COV 2.

A Pagano,G Porta,G Bosso, E Allegorico, C Serra,V Mercurio, G Sansone, S Orefice, F G Numis

The American journal of emergency medicine（2023）

引用 2|浏览2

暂无评分

摘要

In our study, patients who survive SARS CoV-2 ARDS have a fleeting increase in lactate, which precedes clinical improvement by one day.

查看译文

关键词

sars cov,moderate ards

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要